http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102311529-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102311529-B1 |
titleOfInvention | Method and kit for determining the probability that a patient will develop a severe case of dengue |
abstract | Methods and kits for determining the likelihood of a patient developing a severe case of dengue The present invention relates to a method for determining in vitro the likelihood of developing severe dengue in a patient based on a blood sample, said method comprising: a) the amount of at least one marker that is platelet factor 4 in the blood sample is determined, b) the amount of platelet factor 4 determined in step a) is compared with a reference amount of said marker obtained from a group of individuals diagnosed with non-severe dengue, In the above, when the amount of platelet factor 4 determined in step a) is smaller than the reference amount established in step b), it is determined as a patient to develop severe dengue. |
priorityDate | 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.